EU: More Inspections and GMP Non-Compliance Statements
Recommendation
7/8 May 2024
How to foster Continual Quality Improvement
Register now for ECA's GMP Newsletter
The EU GMP inspectorates inspected more drug manufacturing facilities in 2017, according to the 2017 Annual Report from the European Medicines Agency (EMA). Also more inspections are now performed in the EU. Last year 2.122 inspections were conducted by EEA authorities in the EU/EEA (1.956 in 2016) and seven GMP Non-Compliance Statements were issued (five in 2016). Altogether, 2.493 inspections were performed worldwide (2.293 in 2016) leading to 17 GMP Non-Compliance Statements.
On the other hand, according the report, "the number of GMP inspections requests within the context of centralised marketing procedure declined in 2017". This decrease also reflects the implementation of the EU-US MRA. With this agreement, the equivalence of supervisory standards are recognised, inspection reports of the FDA can be accepted and inspections on each other's territories are reduced.
Related GMP News
GMP Conferences by Topics
- General Quality Assurance and GMP Compliance Topics
- Hygiene
- General Microbiology Topics
- Regulatory Affairs
- Development
- General Analytics Topics
- Good Distribution Practice
- Sterile Manufacturing
- Computer Validation
- General Qualification/Validation Topics
- General Engineering Topics
- APIs/Excipients
- GMP Basic Training Courses
- Medical Devices and Combination Products
- Packaging and Packaging Material
- Data Integrity
- Qualified Person (QP)
- GMP Auditing
- Documentation
- Cleaning Validation
- General IT Compliance Topics
- Impurities
- OOS / OOE / OOT
- Material Testing
- Validation of Analytical Methods
- Analytical Instrument Qualification
- Stability Testing
- Microbiological Testing
- Technology
- General Manufacturing Topics
- Solid Dosage Forms/Semi-Solid Dosage Forms
- Biotechnology/Blood/ATMP
- Herbal Drug Products/Cannabis/Radiopharmaceuticals
- Others